Overview
Paul Melot de Beauregard wrote this bylined article about the legal implications of companies, particularly in the pharmaceutical industry, that attempt to stand out from the crowd in the competition for customers. He analyzed the first instance judgment of the Higher Regional Court of Hamburg, which addressed the limits of fair competition.